# 4Tech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/4tech

- Industry: Medical Devices & Equipment
- Headquarters: Galway, Ireland
- Website: www.4techtricuspid.com
- Total disclosed funding: $29M
- Latest round: Series B (Mar 9, 2016)
- Investors on record: 3

## About

4Tech Inc. specializes in innovative technology solutions for cardiac care, focusing on enhancing patient outcomes through advanced monitoring systems and data analytics.Founded in 2010, 4Tech Inc. is based in Galway, Ireland, and develops cutting-edge cardiac monitoring solutions. The company has secured funding through 2 deals, with the latest being a Series B round of USD 29.00 mn raised on March 9, 2016. Investors in this round included NeoMed, RMM, and Valiance.4techtricuspid.com specializes in advanced technology solutions designed to optimize cardiac care and improve patient outcomes. The company's flagship product is an innovative cardiac monitoring system that integrates real-time data analytics with user-friendly interfaces, allowing healthcare professionals to monitor patients' cardiovascular health proactively. This system is primarily aimed at hospitals, clinics, and telemedicine providers seeking to enhance patient engagement and streamline clinical workflows. Additionally, 4techtricuspid.com offers a suite of software solutions that assist in data management and reporting, facilitating informed decision-making for healthcare practitioners. Their products are deployed in various geographical markets, particularly in North America and Europe.The revenue streams of 4techtricuspid.com are generated through a combination of direct-to-consumer sales and B2B partnerships with healthcare institutions. Clients typically engage in subscription-based agreements for access to their cardiac monitoring system, which includes ongoing support and software updates. Transactions are designed to foster long-term relationships, with pricing structures that vary based on the size of the healthcare provider and the specific functionalities required. For instance, larger hospitals may opt for comprehensive packages that include multiple user accounts and enhanced data analytics features, while smaller clinics might select more streamlined options tailored to their operational needs. Each transaction solidifies 4techtricuspid.com’s position within the cardiac care sector by ensuring that its technology is seamlessly integrated into everyday clinical practices.4Tech Inc. plans to leverage the recent funding of USD 29.00 mn from its Series B financing to further enhance its product offerings and expand into new markets. Upcoming launches include advanced features for their cardiac monitoring system designed to improve user engagement, with a target release date in late 2023. The company also aims to enter new regions, specifically targeting expansion into the Asia-Pacific market by 2024 as part of its growth strategy.

## Funding rounds

- Series B, Mar 9, 2016, $29M — NeoMed, Valiance, RMM

## Investors

- NeoMed (https://capitalatlas.ai/funds/neomed) — Series B
- Valiance (https://capitalatlas.ai/funds/valiance) — Series B
- RMM — Series B